Skip to content
CHO-PD-L1
Tissue
Ovary
Disease
Chinese hamster ovary, non-neoplastic; genetically engineered for PD-L1 (CD274/B7-H1) surface expression

Documents

CHO-PD-L1

Cell line · Product number 305975

Disclaimer: The prices displayed for cell lines are exclusively for academic/not-for-profit customers. For commercial entitites the pr...

US$1,900.00excl. tax and shipping
Made to order
1

01General information

Description

Disclaimer: The prices displayed for cell lines are exclusively for academic/not-for-profit customers. For commercial entitites the price is approximately €6,250.
If you represent a commercial entity or are unsure which category applies, please contact us.


CHO-PD-L1 cells are recombinant Chinese hamster ovary (CHO) cells engineered to stably express human programmed death-ligand 1 (PD-L1; CD274/B7-H1), an immune checkpoint ligand that plays a central role in suppression of T-cell-mediated immune responses. PD-L1 is a type I transmembrane protein that interacts primarily with programmed cell death protein 1 (PD-1/CD279) on activated immune cells, leading to inhibition of T-cell proliferation, cytokine production, and cytotoxic activity. Aberrant PD-L1 expression is a common mechanism of immune evasion in multiple solid tumors and hematologic malignancies, making PD-L1-expressing recombinant cell models highly relevant for immuno-oncology research and therapeutic development.

CHO-PD-L1 cells are widely used for the development and characterization of immune checkpoint inhibitors, including monoclonal antibodies, bispecific antibodies, fusion proteins, and engineered cell therapies targeting the PD-1/PD-L1 signaling axis. The stable and controlled expression of PD-L1 enables quantitative evaluation of antibody binding affinity, receptor occupancy, blocking activity, internalization, and ligand-receptor interaction kinetics. These cells are also suitable for flow cytometry assay development, reporter bioassays, T-cell activation studies, and high-throughput screening platforms designed to assess checkpoint blockade efficacy or immune synapse formation. Because CHO cells provide a robust and relatively low-background expression system, they are frequently selected for standardized assay generation and biologic quality control applications.

Tissue
Ovary
Disease
Chinese hamster ovary, non-neoplastic; genetically engineered for PD-L1 (CD274/B7-H1) surface expression
Applications
Antibody screening; PD-L1-targeted immunotherapy development; checkpoint inhibitor research; tumor immune evasion studies; flow cytometry

02Classification

Organism
Chinese hamster
Sex
Female
Growth properties
Adherent and suspension
GMO status
GMO-S1
GMO status details
GMO-S1: This CHO cell line contains a CD274 expression cassette supporting receptor-function analyses. This classification applies only within Germany and may differ elsewhere.
Biosafety level
1

03Characteristics

Morphology
Epithelial-like
Cell type
Epithelial cells
Doubling time
approx. 14-16 hours

04Identifiers

Citation
CHO-PD-L1 (Cytion catalog number 305975)
NCBI TaxID
10029
Cellosaurus
CVCL_A8X1

05Expression and susceptibility

Surface antigens
PD-L1 (CD274/B7-H1)
Receptors expressed
PD-1/CD279

06Handling and culture

Culture medium

For adherent cultures: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)

For suspension cultures: CHO Growth Medium A (from InSCREENeX; InSCREENeX catalog number INS-ME-1039)

Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
For adherent cultures: Supplement the medium with 5% FBS. Add Geneticin (G418-Sulfat) to achieve a final concentration of 0.5 mg/mL.
Dissociation reagent
For adherent cultures: Trypsin-EDTA
Subculturing
For routine adherent cell culture: Aspirate the old culture medium from the adherent cells, and wash them with PBS to remove any remaining medium. After aspirating the PBS, add the appropriate volume of Trypsin/EDTA solution based on the culture vessel size (e.g., 1 ml for a T25 flask, 3 ml for a T75 flask) and incubate at room temperature or 37°C for 5-10 minutes, or until the cells detach. Monitor detachment under a microscope, and gently tap the vessel if necessary to release the cells. Once detached, add complete medium to inactivate the Trypsin/EDTA, gently resuspend the cells, and transfer an aliquot of the cell suspension into a new culture vessel containing fresh medium. Place the vessel in an incubator set to 37°C with 5% CO2, and change the medium every 2-3 days.
Split ratio
1 to 5
Seeding density
2 to 5 x 104 cells/cm2
Fluid renewal
2 to 3 times per week
Post-thaw recovery

After thawing, split the cells at a ratio of 1:2 to 1:3 in T25 flasks and allow the cells to recover from the freezing process and to adhere (for adherent cultures) for at least 24 hours.

Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
Adult